EFPIA - NEWSLETTER

EFPIA Newsletter 06 October 2022

Pushing the boundaries of science for the benefit of patients

EFPIA's 2022 Pipeline Report

Market authorization for 92 new medicines in 2021, a 30% increase in new active substances approved compared to 2020 but Europe is still falling behind other regions of the world in the development of the latest therapies. These are just some of the data published in EFPIA’s recent Pipeline report.

Providing an overview of the latest treatments in development, the Pipeline report is a clear indicator of a pharmaceutical industry at the cutting-edge of science, an industry that continues to invest heavily in finding new treatments for hundreds of medical conditions.

News

05 October 2022 Pharmaceutical industry response to the war in Ukraine

Supporting people affected by the war

Blogs

05 October 2022 Expedited regulatory pathways: A toolbox to provide innovative medicines to patients

For Europe to stand its ground amongst other international regulatory authorities, it is crucial to evolve and future-proof...

05 October 2022 Putting our finger on the pulse of cancer inequalities

The European Cancer Pulse will complement the European Cancer Inequalities Registry by publicly tracking a wide range...

30 September 2022 A fact-based analysis of the TRIPS Waiver extension

A COVID-19 TRIPS waiver extension can harm patients

Events

15 NOV 2022

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION Brussels

An EU Health Coalition event

Learn more →

12 DEC 2022

Enhancing patient-centric outcome measures and clinical trials with Digital Health... Virtual event

Last chance to register!

Learn more →

What we are reading

Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05 October 2022 (Health Policy Watch)

Sustaining rapid medicine development: lessons from a pandemic 04 October 2022 (The Economist)

Access and quality of biomarker testing for precision oncology in Europe 03 October 2022 (Elsevier)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶